| Literature DB >> 21526045 |
Maicon Roberto Kviecinski1, Karina Bettega Felipe, João Francisco Gomes Correia, Eduardo Antonio Ferreira, Maria Helena Rossi, Fernando de Moura Gatti, Danilo Wilhelm Filho, Rozangela Curi Pedrosa.
Abstract
Bidens pilosa is a plant used by Amazonian and Asian folks for some hepatopathies. The hydroethanol crude extract and three fractions were assessed for antioxidant and hepatoprotective effects. Higher levels of scavenger activity on the 1,1-diphenyl-2-picrylhydrazyl radical, inhibition of deoxyribose oxidation and lipid peroxidation in vitro were detected for the ethyl acetate fraction (IC(50)~4.3-32.3 µg/ml) followed by the crude extract (IC(50)~14.2-98.0 µg/ml). The ethyl acetate fraction, again followed by the crude extract, showed high contents of total soluble polyphenols (3.6±0.2 and 2.1±0.2 GAE/mg, respectively) and presence of a quercetin-derived flavonoid identified as quercetin 3,3'-dimethyl ether 7-O-β-D-glycopyranoside. Both products were assayed for hepatoprotector effects against CCl(4)-induced liver injury in mice. Markers of oxidative stress and hepatic injury were evaluated. The results showed that the 10-day pretreatments (15 mg/kg, p.o.) protected the livers against injury by blocking CCl(4)-induced lipid peroxidation and protein carbonylation and the DNA fragmentation was decreased (~60%). The pretreatments avoided the loss of the plasma ferric reducing/antioxidant power and the elevation of serum transaminases and lactate dehydrogenase activities. The results suggest that the main constituents responsible for the hepatoprotective effects with free radical scavenger power associated are well extracted by performing fractionation with ethyl acetate. The findings support the Brazilian traditional use of this plant and justify further evaluations for the therapeutic efficacy and safety of the constituents of the ethyl acetate fraction to treat some liver diseases.Entities:
Keywords: Bidens pilosa L.; CCl4 toxicity; ethyl acetate fractionation; free radical scavenger; hepatoprotection; hydroethanol maceration
Year: 2011 PMID: 21526045 PMCID: PMC3081874 DOI: 10.3402/ljm.v6i0.5651
Source DB: PubMed Journal: Libyan J Med ISSN: 1819-6357 Impact factor: 1.657
Groups of animals, experimental pretreatments, and challenge
| Group | 10-day pretreatment | Dose | Challenge on day 11 |
|---|---|---|---|
| Normal control group (NC) | Vehicle | 0.5 ml | None |
| Negative control group (NEG) | Vehicle | 0.5 ml | CCl4 |
| Positive control group (SIL) | Silymarin | 15 mg/kg | CCl4 |
| HCE group | HCE | 15 mg/kg | CCl4 |
| f-EtOAc group | f-EtOAc | 15 mg/kg | CCl4 |
Activity of Bidens pilosa (hydroethanol crude extract and fractions) or Silymarin (0.5 to 500 µg/ml) on scavenging of 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH) and hydroxyl radicals (•OH), inhibition of lipid peroxidation in vitro (LPO), and total polyphenol content in the plant samples (TPC)
| Sample | DPPH IC50 (µg/ml) | OH IC50 (µg/ml) | LPO IC50 (µg/ml) | TPC (GAE/mg) |
|---|---|---|---|---|
| HCE | 98.0±1.0 | 14.2±3.2 | 35.8±3.9 | 2.1±0.2 |
| f-EtOAc | 32.3±6.7 | 4.3±1.5 | 25.1±4.5 | 3.6±0.2 |
| f-MeOH | 102.9±2.4 | 18.5±8.2 | 90.4±3.4 | 1.0±0.1 |
| f-CHCl3 | 248.0±1.8 | 33.0±6.0 | 166.3±2.6 | 0.8±0.1 |
| Silymarin | 13.9±0.7 | 7.6±0.8 | 10.1±4.5 | – |
Note: Hydroethanol crude extract (HCE), ethyl acetate fraction (f-EtOAc), methanol fraction (f-MeOH), and chloroform fraction (f-CHCl3). Values are expressed as means±SD (n=3). IC50: half maximal inhibitory concentration was obtained by linear regression.
Denotes significant differences at P < 0.05 in comparison to the positive control (SIL).
In comparison to HCE, f-MeOH, or f-CHCl3.
Effects on the plasma ferric reducing/antioxidant power (FRAP), hepatic reduced glutathione content (GSH), and hepatic catalase activity (CAT) in mice pretreated with the hydroethanol crude extract (HCE) or the ethyl acetate fraction (f-EtOAc) from Bidens pilosa (15 mg/kg, p.o., 10 days), after CCl4 on day 11 (0.5 ml/kg, i.p.), and controls
| Biomarkers of oxidative damage and antioxidant defenses | |||
|---|---|---|---|
| Group | FRAP (mM) | GSH (µmol/g) | CAT (mmol/min.g) |
| NC | 21.7±0.7 | 34.1±3.1 | 163.7±29.6 |
| NEG | 11.7±0.8 | 8.1±3.6 | 517.6±67.9 |
| f-EtOAc | 20.7±0.7 | 30.1±0.4 | 366.4±44.9 |
| HCE | 18.9±0.9 | 25.8±1.5 | 447.1±33.1 |
| Silymarin | 24.5±2.0 | 29.8±4.2 | 441.6±44.3 |
Note: Values are expressed as means ± SD (n=6).
Denotes significant statistic differences at P<0.05 in comparison to the negative control group (NEG).
In comparison to the normal control group (NC).
Fig. 1CCl4 led to increased levels of hepatic lipid peroxidation in treated mice from the negative control group (NEG) compared to the normal control group (NC). The ethyl acetate fraction (f-EtOAC), hydroethanol crude extract (HCE), and the positive control Silymarin (SIL) protected livers from pretreated mice against lipid peroxidation (A); animals from the negative control group (NEG) treated by CCl4 presented increased levels of carbonyl proteins compared to the normal control group (NC). The f-EtOAC, HCE, and the positive control Silymarin (SIL) protected livers from pretreated mice against oxidative damage to proteins (B). All values are expressed as means±SD, n=6. aDenotes significant statistic difference compared to NEG (P<0.05).
Effects of the hydroethanol crude extract (HCE) and the ethyl acetate fraction (f-EtOAc) from B. pilosa and Silymarin against the hepatotoxicity induced in mice by CCl4
| Serum enzymes | |||
|---|---|---|---|
| Group | AST (U/L) | ALT (U/L) | LDH (U/L) |
| NC | 9.1±1.1 | 29.2±3.5 | 237.2±38.3 |
| NEG | 68.4±1.6 | 91.0±1.5 | 541.4±41.2 |
| f-EtOAc | 12.3±1.4 | 33±10 | 272.4±33.7 |
| HCE | 21.3±0.9 | 48.0±2.1 | 295.1±29.3 |
| Silymarin | 24.4±1.4 | 53.0±2.5 | 289.6±30.5 |
Denotes significant statistic differences at P<0.05 in comparison to the negative control group (NEG).
In comparison to the normal control group (NC).
Note: Values are expressed as means±SD (n=6).
Abbreviations: Alanine aminotransferase (ALT); aspartate aminotransferase (AST); lactate dehydrogenase (LDH).
Fig. 2DNA damage index (0–400) in hepatocytes from mice from the normal control group (NC), negative control group (NEG), positive control group pretreated with Silymarin at 15 mg/kg, p.o. (SIL), and from mice pretreated with the extracts from Bidens pilosa, the hydroethanol crude extract (HCE) or fraction ethyl acetate (f-EtOAc) both at 15 mg/kg (p.o) and on the 11th day treated with CCl4 (0.5 ml/kg, i.pl). All values are expressed as means ± SD, n=6. aDenotes significant difference compared to NEG (P<0.05).